uniQure Announces Conference Call and Webcast to Discuss Topline Results From Low-Dose Cohort in Hemophilia B Phase I/II Gene...
January 06 2016 - 4:15PM
uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today
announced that the Company will release topline results from its
Hemophilia B Phase I/II gene therapy low-dose cohort clinical trial
through a press release at 06:00 EST/12:00 CET on January 7, 2016.
The Company's management team will hold a conference call and
webcast at 08:30 EST/14:30 CET after the press release has been
issued to discuss the update.
The conference call can be accessed by dialing one of the
numbers listed below five minutes prior to the start of the call
and providing the confirmation code: 1640435. The
webcast, including accompanying slides also available as a PDF
file, can be accessed through the link displayed in the "Events"
section on the "Media" page of the uniQure website at
http://www.uniqure.com/news/calendar-of-events/. The webcast replay
will be available for at least 72 hours following the call.
Conference Call Numbers
London, United
Kingdom: |
+44 (0) 20 3427
1906 |
New York, United
States of America: |
+1 212 444
0412 |
Berlin,
Germany: |
+49 (0) 30 3001
90534 |
Amsterdam,
Netherlands: |
+31 (0) 20 716
8296 |
Paris,
France: |
+33 (0) 1 76 77 22
31 |
Milan,
Italy: |
+39 02 3859
1420 |
Brussels,
Belgium: |
+32 (0) 2 402
3092 |
Montreal,
Canada: |
+1 514 841
2154 |
About uniQure
uniQure is delivering on the promise of gene therapy – single
treatments with potentially curative results. We are leveraging our
modular and validated technology platform to rapidly advance a
pipeline of proprietary and partnered gene therapies to treat
patients with CNS, liver/metabolic and cardiovascular diseases.
www.uniQure.com
CONTACT: uniQure:
Direct: +31 20 240 6110
Main: +31 20 240 6000
e.mulder@uniQure.com
Media inquiries:
Gretchen Schweitzer
MacDougall Biomedical Communications
Direct: +49 172 861 8540
Main: +49 89 2424 3494 or
+1 781 235 3060
gschweitzer@macbiocom.com
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024